HPV İlişkili Kanserlere Karşı Mücdelede HPV Aşıları Hakkında Derleme

Immunobiology of HPV and HPV vaccines.

Genital human papillomavirus (HPV) infection with both low- and high-risk types is common, but most infections resolve as a result of a cell-mediated immune response. Failure to induce an effective immune response is related to inefficient activation of innate immunity and ineffective priming of the adaptive immune response; this defective immune response facilitates viral persistence, a key fe...

HPV & HPV vaccination: issues in developing countries.

Cervical cancer is the second-most common cancer in women worldwide causing most cancer related deaths in women in developing countries including India. The most predominant etiological factor for cervical cancer is persistent infection of certain high-risk types of human papillomaviruses (HR-HPVs), while low-risk types are associated with benign cervical lesions and genital warts. In India, th...

پیشگیری ،HPV ،سرطان سرویکس، واکسیناسیون

Cervical cancer is the second most common gynecologic cancer. A steady 70% annual decline in mortality from cervical cancers has been observed since the mid 20th century after the introduction of widespread papanicolaou cytological screening. But also cervical cancer continues to be an important world health problem for women. Cervical cancer is one of the best- understood neoplasm given its we...

Reduction in HPV prevalence--no evidence to support HPV vaccination reduces HPV prevalence.

world assumptions [9–11]. In particular, a re-analysis of data from 4 randomized clinical trials (RCTs) found that efficacy estimates and confidence intervals for the gold standard RCT analysis and the alternative TND analysis were virtually identical [11]. Other than age, confounding variables have been notably absent in most vaccine effectiveness studies using theTND.Medicationconfoundingmayb...

Human papillomavirus (HPV) and HPV-associated tumour vaccines.